ES2159358T3 - Procedimiento para elaborar preparaciones de liposomas. - Google Patents

Procedimiento para elaborar preparaciones de liposomas.

Info

Publication number
ES2159358T3
ES2159358T3 ES96918002T ES96918002T ES2159358T3 ES 2159358 T3 ES2159358 T3 ES 2159358T3 ES 96918002 T ES96918002 T ES 96918002T ES 96918002 T ES96918002 T ES 96918002T ES 2159358 T3 ES2159358 T3 ES 2159358T3
Authority
ES
Spain
Prior art keywords
preparations
liposomas
preparing
procedure
portions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96918002T
Other languages
English (en)
Inventor
Carl L Alving
Roberta R Owens
Nabila M Wassef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Army
Original Assignee
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23888222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2159358(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by US Department of Army filed Critical US Department of Army
Application granted granted Critical
Publication of ES2159358T3 publication Critical patent/ES2159358T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA FABRICAR UNA PREPARACION DE LIPOSOMAS FORMADA POR LIPOSOMAS QUE CONTIENEN UN MATERIAL ENCAPSULADO. EL PROCEDIMIENTO INCLUYE (A) SUMINISTRAR MULTIPLES PORCIONES DE UN FORMULADO DE LIPIDOS O DE LIPOSOMAS; (B) HIDRATAR CADA UNA DE LAS MULTIPLES PORCIONES CON UNA SOLUCION QUE INCLUYE UN MATERIAL QUE VA A SER ENCAPSULADO; Y (C) COMBINAR CADA UNA DE LAS MULTIPLES PORCIONES PARA FORMAR UNA SOLA PREPARACION DE LIPOSOMAS. LAS PREPARACIONES DE LIPOSOMAS PUEDEN UTILIZARSE PARA LA ADMINISTRACION DE FARMACOS O COMO VACUNAS.
ES96918002T 1995-06-07 1996-06-06 Procedimiento para elaborar preparaciones de liposomas. Expired - Lifetime ES2159358T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/475,581 US6007838A (en) 1995-06-07 1995-06-07 Process for making liposome preparation

Publications (1)

Publication Number Publication Date
ES2159358T3 true ES2159358T3 (es) 2001-10-01

Family

ID=23888222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96918002T Expired - Lifetime ES2159358T3 (es) 1995-06-07 1996-06-06 Procedimiento para elaborar preparaciones de liposomas.

Country Status (12)

Country Link
US (1) US6007838A (es)
EP (1) EP0831779B2 (es)
JP (1) JP2000514035A (es)
AT (1) ATE203898T1 (es)
AU (1) AU699055B2 (es)
CA (1) CA2223808A1 (es)
DE (1) DE69614385T3 (es)
DK (1) DK0831779T4 (es)
ES (1) ES2159358T3 (es)
IL (1) IL122486A (es)
PT (1) PT831779E (es)
WO (1) WO1996040063A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1030652B1 (en) * 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
EP1268305B1 (en) 2000-03-21 2007-09-12 Suzanne Jaffe Stillman Infusion packet with useful and decorative elements, support member, delivery system and method
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
AU2001278981A1 (en) * 2000-07-21 2002-02-05 Tom F Lue Prevention and treatment of sexual arousal disorders
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
EP2823809B1 (en) 2002-06-28 2016-11-02 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
WO2004015099A2 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
WO2007012191A1 (en) 2005-07-27 2007-02-01 Protiva Biotherapeutics, Inc. Systems and methods for manufacturing liposomes
WO2007049279A2 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem A liposomal combination and uses thereof
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
NO329127B1 (no) * 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
JP2012526133A (ja) 2009-05-05 2012-10-25 ベイポジェニックス インコーポレイテッド 炎症を低減させるための新規揮発性麻酔薬製剤およびその使用法
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
CN113712911A (zh) 2013-03-15 2021-11-30 维普詹尼克斯公司 新型镇痛组合物
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
WO2018201022A1 (en) * 2017-04-28 2018-11-01 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compositions and methods for vaccine delivery
CN114126600B (zh) * 2020-01-20 2024-03-08 广州谷森制药有限公司 三苯乙酸维兰特罗的脂质体制剂
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) † 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
JPS63502117A (ja) * 1986-02-10 1988-08-18 リポソ−ム　テクノロジ−，インコ−ポレイテッド 放出を制御されたリポソ−ム供給系
US4752425A (en) † 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
US5631237A (en) † 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2714601B1 (fr) † 1993-12-30 1996-02-09 Oreal Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.

Also Published As

Publication number Publication date
AU6036596A (en) 1996-12-30
US6007838A (en) 1999-12-28
IL122486A0 (en) 1998-06-15
EP0831779B2 (en) 2005-01-19
EP0831779B1 (en) 2001-08-08
JP2000514035A (ja) 2000-10-24
DE69614385D1 (de) 2001-09-13
ATE203898T1 (de) 2001-08-15
AU699055B2 (en) 1998-11-19
DK0831779T3 (da) 2001-10-08
DE69614385T3 (de) 2005-05-25
DK0831779T4 (da) 2005-06-06
IL122486A (en) 2000-07-16
PT831779E (pt) 2001-11-30
DE69614385T2 (de) 2002-05-23
CA2223808A1 (en) 1996-12-19
WO1996040063A1 (en) 1996-12-19
EP0831779A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
ES2159358T3 (es) Procedimiento para elaborar preparaciones de liposomas.
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
GEP20022734B (en) Pharmaceutical Preparation Comprising Lyophilized Liposomes Encapsulating an Active Principle Which Is Highly Insoluble in Water, and the Process for Preparing the Said Preparation
EP0280492A3 (en) Liposome composition and its production
GR1000074B (el) Λιποειδη σφαιριδια (κυστιδια) για ενδοπεριτονειακη χορηγηση θεραπευτικων παραγοντων.
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
DE69332276D1 (de) Liposomenzusammensetzung
JPS5622724A (en) Pharmaceutical preparation of n4-acylcytosine arabinoside
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
DE59510668D1 (de) Unilamellare liposomenzubereitungen mit hohem wirkstoffanteil
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
EP0198765A3 (en) Preparation of liposomes
ATE144415T1 (de) Liposomen
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
HUT62457A (en) Process for producing aqueous liposomal suspensions comprising an active ingredient
DE3878696D1 (de) Liposome, ihre herstellung und anwendung als vektor von arzneimitteln.
NO171295C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av et biologisk aktivt konjugert protein
IT8820260A0 (it) 1,2_di_0_acetil_glicero_3_difosfato di l_carnitina e degli esteri della l_carnitina, procedimento per la sua preparazione e formulazioni farmaceutiche che li contengono.
IT8820482A0 (it) 1,2 di acetil glicero fosfato di l acetil carnitina e degli esteri della l acetil carnitina, procedimento per la sua preparazione e formulazioni farmaceutiche che li contengono.
IT1268454B1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 831779

Country of ref document: ES